EICHOR
● Enrolling By Invitation
An Open-Label Study of Azetukalner in Major Depressive Disorder
Condition: Major Depressive Disorder · Sponsor: Xenon Pharmaceuticals Inc.
About this study
X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult participants who successfully completed an antecedent Phase 3 study of azetukalner in Major Depressive Disorder (MDD).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (68)
| Ima Clinical Research - Phoenix | Phoenix, Arizona, United States | — |
| Sanro Clinical Research Group, Llc | Bryant, Arkansas, United States | — |
| Woodland International Research Group | Little Rock, Arkansas, United States | — |
| Woodland Research Northwest | Rogers, Arkansas, United States | — |
| Cenexel Cit - Bellflower | Bellflower, California, United States | — |
| Calneuro Research Group, Inc. | Los Angeles, California, United States | — |
| Excell Research Inc. | Oceanside, California, United States | — |
| Atp Clinical Research | Orange, California, United States | — |
| Nrc Research Institute | Orange, California, United States | — |
| Artemis Institute For Clinical Research - San Diego | San Diego, California, United States | — |
| Cenexel Cnr - Sherman Oaks | Sherman Oaks, California, United States | — |
| Cenexel Cns - Torrance | Torrance, California, United States | — |
+ 56 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06922110